|
Symbol
|
RMA93V | RMBA5V | CCCBKB | RMALEV | RMAQ2V | OYCRCH | RMBM5V | CISBKB | RMADDV | KZNEDU | KZKXDU | ACBOTQ | ACBESQ | ACCXTQ | RMBB7V | ACEQTQ | RMBNYV | RMBT8V | PTHRCH | PTVRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Worst of Reverse Convertible |
|
Basiswert
|
Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG / Straumann Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Holcim/Amrize Basket / Lonza Group N / Partners Group Hldg. AG / Sonova Hldg. AG | Lonza Group N / Nestlé S.A. / Novartis AG / Roche PS / Straumann Hldg. AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Lonza Group N / Partners Group Hldg. AG / Swiss RE AG | ABB N / Givaudan / Lonza Group N | Geberit AG / Logitech International SA / Lonza Group N / Sika AG | Julius Baer Group / Lonza Group N / Partners Group Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Sonova Hldg. AG | Compagnie Financière Richemont SA / Holcim/Amrize Basket / Lonza Group N | Holcim/Amrize Basket / Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Lonza Group N / Partners Group Hldg. AG / Sandoz Group AG / Swiss RE AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Lonza Group N / Sika AG / Straumann Hldg. AG | Companie Financière Richemont SA / Lonza Group N / Partners Group Hldg. AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
12.01.2027 | 05.01.2027 | 09.02.2027 | 15.03.2027 | 19.04.2027 | 01.04.2027 | 11.10.2027 | 25.08.2027 | 05.01.2027 | 05.02.2027 | 15.01.2027 | 10.02.2027 | 17.02.2027 | 17.02.2027 | 15.02.2027 | 24.05.2027 | 08.03.2027 | 23.11.2026 | 07.12.2026 | 07.12.2026 |
| Geld | 100.60 | 100.70 | 100.48 | 61.90 | 98.80 | 87.46 | 95.10 | 96.50 | 100.20 | 46.500 | 100.50 | 77.99 | 46.050 | 93.97 | 100.06 | 101.62 | 49.000 | - | 80.56 | 47.890 |
| Brief | 101.60 | 101.70 | 101.34 | - | 99.80 | 88.31 | 96.10 | 97.35 | 101.20 | 47.500 | 101.50 | - | - | - | 101.30 | 102.49 | - | - | - | - |